Hepatitis C treatment outcomes in Australian clinics

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

2002 • 6,505 citations

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

2001 • 6,133 citations

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

2003 • 4,023 citations

Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C

2004 • 2,888 citations

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

2011 • 2,514 citations

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

2011 • 2,404 citations

Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels

2002 • 1,415 citations

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

2004 • 1,249 citations

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

2009 • 1,176 citations

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis

2010 • 962 citations

Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons

2004 • 885 citations

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

2010 • 734 citations

Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence

2009 • 233 citations

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy

2010 • 145 citations

Therapeutics: New drugs hit the target

2011 • 62 citations

Predictors of deferral of treatment for hepatitis C infection in Australian clinics

2011 • 48 citations

Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments

2010 • 46 citations

Future hepatitis C virus treatment: interferon‐sparing combinations

2011 • 41 citations

The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients

2010 • 34 citations

Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: A Danish nationwide cohort study

2011 • 29 citations

Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

2010 • 28 citations

Cholesterol and chronic hepatitis C virus infection

2011 • 20 citations

Effectiveness of interferon alfa‐2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting

2003 • 19 citations